Covid-19 and Mental Health
Fear, anxiety, and stress are normal responses to perceived or real threats and sometimes when we encounter uncertainty or the unknown. So it is common and understandable that people are experiencing fear in the wake of the COVID-19 pandemic. Since the onset of the COVID-19 epidemic, unemployment and economic instability, disruption to education, social loneliness, fear of close partner and family violence, fear of life-threatening illness, and sudden loss of loved ones are all too common. All of these are risk factors for mental health conditions and behavioral problems such as depression and substance abuse disorders.
In addition to the fear of contracting a virus in an epidemic such as COVID-19, significant changes are made in our daily lives as our movements are restricted in support of efforts to stop and slow the spread of the virus. When faced with new realities such as working from home, temporary unemployment, having children at home, and not having physical contact with other family members, friends, and co-workers, we need to manage our mental, as well as our physical health.
- Bereavement
- Isolation
- Loss of income
- Insomnia
- Drug use
- Harmful alcohol
- Suicidal behaviour
Related Conference of Covid-19 and Mental Health
5th International Conference on Microbiology and Infectious Diseases
11th International Conference on Infectious and Rare Diseases
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
20th World Conference on Infectious Diseases, Prevention and Control
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Covid-19 and Mental Health Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Epidemiology - Infection Prevention 2025 (UK)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Neuro Infections - Infection Prevention 2025 (UK)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Public Health - STD-HIV AIDS-2025 (USA)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)